Rojan Shrestha

Title: Rojan Shrestha: Innovator in Immunotherapy

Introduction

Rojan Shrestha is a prominent inventor based in the Bronx, NY. She has made significant contributions to the field of immunotherapy, particularly through her innovative research on the PD-1 receptor. Her work focuses on developing mutant variants of the PD-1 receptor that selectively bind to PD-L1, which has important implications for cancer treatment and imaging.

Latest Patents

Rojan Shrestha holds a patent titled "Mutant variants of PD-1 receptor with selective binding to PD-L1 and uses thereof." This patent discloses human Programmed Cell Death-1 (PD-1) receptor mutants that exhibit selectivity for PD-L1 compared to PD-L2. The patent also outlines methods for obtaining these mutants and their potential uses in therapeutic and imaging applications. She has 1 patent to her name.

Career Highlights

Rojan Shrestha is affiliated with the Albert Einstein College of Medicine, where she conducts her research. Her work has garnered attention for its potential to enhance cancer therapies by targeting specific pathways in immune response.

Collaborations

Rojan collaborates with esteemed colleagues, including Andras Fiser and Steven Craig Almo. Their combined expertise contributes to the advancement of research in immunotherapy and related fields.

Conclusion

Rojan Shrestha is a trailblazer in the field of immunotherapy, with her innovative research paving the way for new treatment options. Her contributions to the understanding of PD-1 receptor mutants highlight the importance of targeted therapies in modern medicine.